Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers
Hans‐Jürgen Möller, Hans‐Peter Volz, Erich Seifritz, et al.
Journal of Psychiatric Research (2020) Vol. 136, pp. 543-551
Open Access | Times Cited: 10

Showing 10 citing articles:

Silexan is well-tolerated for long-term use in adults and for treatment of adolescents: a real-world data analysis
Hans‐Peter Volz, Thomas Rosemann, Martin Burkart, et al.
European Archives of Psychiatry and Clinical Neuroscience (2025)
Open Access
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
Markus Dold, Lucie Bartova, Hans‐Peter Volz, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1615-1628
Open Access | Times Cited: 10
Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data
Siegfried Kasper, Anne Eckert
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 2
Effect of anxiolytic drug silexan on sleep – a narrative review
Erich Seifritz, Siegfried Kasper, Hans‐Jürgen Möller, et al.
The World Journal of Biological Psychiatry (2022) Vol. 23, Iss. 7, pp. 493-500
Open Access | Times Cited: 9
Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan
Siegfried Kasper, Anne Eckert, Hans‐Jürgen Möller, et al.
International Journal of Psychiatry in Clinical Practice (2023) Vol. 27, Iss. 3, pp. 285-291
Open Access | Times Cited: 5
How to treat subsyndromal anxiety disorder – practical recommendations for implementation in primary care
Daniel L. Costa, Rodolfo Furlan Damiano, J.Á. Cuesta Alcalá, et al.
International Journal of Psychiatry in Clinical Practice (2024), pp. 1-10
Closed Access
Die Rolle von Phytotherapie bei COVID-19-assoziierter Angst und Depression
Jan Zourek, Rainer Stange, Siegfried Kasper, et al.
Zeitschrift für Phytotherapie (2024) Vol. 45, Iss. 04, pp. 148-156
Closed Access
Lavender improves sleep through olfactory perception and GABAergic neurons of the central amygdala
Yanli Ren, Weiwei Chu, Xing-Wen Yang, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118942-118942
Open Access
A scoping review of motor vehicle operator performance assessments for benzodiazepine receptor agonists
Andrea Murphy, Korolos Sawires, Sophie Peltekian, et al.
Exploratory Research in Clinical and Social Pharmacy (2024) Vol. 16, pp. 100538-100538
Open Access
Lavendel bei Angststörungen – Schwerpunkt Lavendelöl
Hans‐Peter Volz
Zeitschrift für Phytotherapie (2022) Vol. 43, Iss. 03, pp. 105-111
Closed Access | Times Cited: 1
Page 1

Scroll to top